Verastem, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Verastem, Inc. on November 14, 2019. The filing details a material definitive agreement involving the restructuring of the Company's debt obligations through an exchange of existing notes for new convertible senior notes and an amendment to its credit facility.
Key Financial Metrics and Debt Structure
- New Debt Issuance: Issued approximately $62.9 million aggregate principal amount of 5.00% Convertible Senior Second Lien Notes due 2048.
- Debt Exchange: Investors exchanged approximately $114.3 million of existing 5.00% Convertible Senior Notes due 2048 for the new Notes.
- Remaining Existing Debt: Following the exchange, approximately $35.7 million of the Existing Notes remains outstanding.
- Interest Rate: The new Notes bear interest at 5.00% per year, payable semiannually.
- Maturity Date: November 1, 2048.
- Liquidity and Cash Flow: The filing does not provide specific values for revenue, profit, operating cash flow, or current liquidity ratios.
Material Changes Versus Prior Period
The primary material change is the alteration of the Company's capital structure. The Company reduced its outstanding principal of the original 2048 notes by approximately $114.3 million while simultaneously increasing its secured debt obligations by $62.9 million. The new Notes are senior secured obligations, whereas the existing notes were likely unsecured or differently ranked, subject to the specific terms of the prior indenture. The new Notes are structurally subordinated to subsidiary liabilities.
Guidance, Outlook, and Risks
- Credit Facility Amendment: The Company amended its senior secured credit facility with Hercules Capital, Inc. to consent to the exchange transaction and the issuance of the new Notes.
- Covenants: The amendment imposes certain liquidity thresholds and financial covenants on the Company.
- Subordination: The liens securing the new Notes are subordinated to the liens in favor of the Agent under the credit facility.
- Outlook: The filing does not contain specific forward-looking guidance regarding revenue or clinical milestones.
Key Facts for Investor Verification
- Verify the specific liquidity thresholds and financial covenants imposed by the Credit Facility Amendment with Hercules Capital, Inc.
- Confirm the conversion terms and pricing of the new 5.00% Convertible Senior Second Lien Notes due 2048.
- Review the remaining $35.7 million of Existing Notes to understand their current seniority and terms relative to the new Notes.
- Assess the impact of the new debt service obligations (5.00% interest) on the Company's cash burn rate.